The MindBody GLP-1 system combines two complementary products
After entering cells, DCFH-DA converts to DCFH and forms fluorescent dichlorofluorescein when oxidized by ROS
Collective data from major clinical trials have shown that treatment with a DPP-4i improves glycemic control by increasing insulin secretion from islet cells, lowering levels of HbA1c, reducing adipocyte size, and suppressing inflammation [47,48,49,50,51]
The tyrosine-derived fragment contributes an aromatic phenolic ring system, while the isoleucine-derived segment introduces a branched aliphatic side chain
Zhou, F.-f et al
This area of research has been inspired by Otto Warburg's observations in 1922, wherein he discovered the specific glucose consumption by cancer cells through the Warburg metabolic pathway [2]